Literature DB >> 11600613

Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study.

V Gebbia, F Giuliani, E Maiello, G Colucci, F Verderame, N Borsellino, G Mauceri, M Caruso, M L Tirrito, M Valdesi.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11600613     DOI： 10.1200/JCO.2001.19.20.4089

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  29 in total

1.  A phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable biliary tract cancer.

Authors:  Tsuyoshi Hayashi; Hirotoshi Ishiwatari; Makoto Yoshida; Tsutomu Sato; Koji Miyanishi; Yasushi Sato; Masayoshi Kobune; Rishu Takimoto; Tomoko Sonoda; Junji Kato
Journal:  Int J Clin Oncol       Date:  2011-09-21       Impact factor: 3.402

Review 2.  Targeted therapy in biliary tract cancers-current limitations and potentials in the future.

Authors:  Selley Sahu; Weijing Sun
Journal:  J Gastrointest Oncol       Date:  2017-04

Review 3.  Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic function.

Authors:  Jun Gong; May Cho; Marwan Fakih
Journal:  J Gastrointest Oncol       Date:  2017-04

Review 4.  Signaling pathways as therapeutic targets in biliary tract cancer.

Authors:  Jennifer Yang; Matthew R Farren; Daniel Ahn; Tanios Bekaii-Saab; Gregory B Lesinski
Journal:  Expert Opin Ther Targets       Date:  2017-03-17       Impact factor: 6.902

Review 5.  Current management of gallbladder carcinoma.

Authors:  Andrew X Zhu; Theodore S Hong; Aram F Hezel; David A Kooby
Journal:  Oncologist       Date:  2010-02-10

Review 6.  Advances in the management of biliary tract cancers.

Authors:  Kristen Keon Ciombor; Laura Williams Goff
Journal:  Clin Adv Hematol Oncol       Date:  2013-01

7.  Establishment of a novel orthotopic xenograft model of human gallbladder carcinoma.

Authors:  Jan-Hendrik Egberts; Bodo Schniewind; Clemens Schafmayer; Marie-Luise Kruse; Bence Sipos; Fred Fändrich; Holger Kalthoff; Jürgen Tepel
Journal:  Clin Exp Metastasis       Date:  2007-04-04       Impact factor: 5.150

8.  A Case of Common Bile Duct Cancer That Completely Responded to Combination Chemotherapy of Gemcitabine and TS-1.

Authors:  Joo Hyun Lim; Ji Kon Ryu; Yoon Jin Choi; Jieun Kwon; Ji Yeon Kim; Yun Bin Lee; Jae Hwan Kim; Won Jae Yoon; Yong Tae Kim; Yong Bum Yoon
Journal:  Gut Liver       Date:  2013-05-13       Impact factor: 4.519

9.  Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double-blind randomized crossover study.

Authors:  Hiroki Nagai; Toshiyuki Kitano; Takafumi Nishimura; Hiroyasu Yasuda; Kazumi Nakata; Sachie Takashima; Masashi Kanai; Shigemi Matsumoto; Yukiko Mori; Yuichi Kakudo; Hiroyasu Sato; Takuhiro Yamaguchi; Kaoru Kameno; Young Hak Kim; Michiaki Mishima; Kazuhiro Yanagihara
Journal:  Support Care Cancer       Date:  2013-07-23       Impact factor: 3.603

10.  Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer.

Authors:  Jeffrey A Meyerhardt; Andrew X Zhu; Keith Stuart; David P Ryan; Lawrence Blaszkowsky; Nicole Lehman; Craig C Earle; Matthew H Kulke; Pankaj Bhargava; Charles S Fuchs
Journal:  Dig Dis Sci       Date:  2007-06-29       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.